Cointime

Apothecary Capital

investment firm

About

Apothecary Capital is an Illinois-based venture capital firm that provides financial advisory services.

  • Chicago,Illinois,United States

Highlights

Investments
5
Lead Investments
1
Exits
4
Employee Profiles
1

Details

Operating Status
Active
Investor Type
Venture Capital

Investments

Number of Investments
Number of Lead Investments
5
1
Apothecary Capital has made 5 investments. Their most recent investment was on Jul 1, 2008, when Portola Pharmaceuticals raised $60.09M.
Date Company Name
Round Money Raised Industry Lead Investor
Jul 1, 2008 Portola Pharmaceuticals
Series C $60.09M Biopharma —
May 19, 2008 Kythera Biopharmaceuticals
Series C $30M Biopharma —
Dec 21, 2007 Cogentus Pharmaceuticals
Series C $62.50M Biotechnology —
Jan 8, 2007 Calypso Medical
Series D $42.20M Health Care Yes
Feb 17, 2005 FibroGen
Series Unknown $100M Biopharma —

Employee Profiles

Number of Employee Profiles
1
Apothecary Capital has 1 current employee profiles, including Executive Alan M. Sebulsky
Alan M. Sebulsky
Executive

Exits

Apothecary Capital has had 4 exits. Apothecary Capital most notable exits include FibroGen ,   Portola Pharmaceuticals

Date Company Name Exit Type Industry
Nov 21, 2014 FibroGen IPO Biopharma Detail
May 23, 2013 Portola Pharmaceuticals M&A Biopharma Detail
Oct 11, 2012 Kythera Biopharmaceuticals M&A Biopharma Detail
Sep 19, 2011 Calypso Medical M&A Health Care Detail
Cointime
Content
Company